Patents by Inventor Philippe Diaz

Philippe Diaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydrazone modulators of cannabinoid receptors
    Patent number: 8309595
    Abstract: Hydrazone compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: November 13, 2012
    Assignee: Board of Regents, The University of Texas System
    Inventors: Mohamed Naguib Attala, Philippe Diaz
  • Novel Tricyclic Modulators of Cannabinoid Receptors
    Publication number: 20120039804
    Abstract: The compounds of the invention are modulators of cannabinoid receptors CB1 or CB2. The compounds can be used for the prevention or treatment of, e.g., pain, cancer, skin diseases, weight-associated disorders, chemical addictions, psychiatric disorders, neurodegenerative disorders, bone diseases, and inflammatory diseases. The compounds of the invention can further be used to study these diseases and disorders, as well as cannabinoid receptor biology, by coupling the compounds to, e.g., imaging agents.
    Type: Application
    Filed: June 6, 2011
    Publication date: February 16, 2012
    Inventors: Philippe Diaz, Fanny Diaz, Ravil Rashitovich Petrov
  • Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
    Patent number: 7829588
    Abstract: Novel compounds that are modulators of PPAR-type receptors having the structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and in the field of cardiovascular diseases, immune diseases and/or diseases linked to the metabolism of lipids), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: November 9, 2010
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin
  • HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS
    Publication number: 20100204220
    Abstract: Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
    Type: Application
    Filed: July 14, 2008
    Publication date: August 12, 2010
    Inventors: Mohamed Naquib Attala, Philippe Diaz
  • HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS
    Publication number: 20100197755
    Abstract: Hydrazone compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
    Type: Application
    Filed: July 14, 2008
    Publication date: August 5, 2010
    Inventors: Mohamed Naguib Attala, Philippe Diaz
  • Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Patent number: 7592478
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: September 22, 2009
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20080213347
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Application
    Filed: October 30, 2007
    Publication date: September 4, 2008
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Patent number: 7348449
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: March 25, 2008
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Novel biaromatic compounds that modulate PPAR type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20080004274
    Abstract: Novel biaromatic compounds having the general formula (i) below: and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/or of diseases related to the metabolism of lipids) or, alternatively, in cosmetic compositions.
    Type: Application
    Filed: June 14, 2007
    Publication date: January 3, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Philippe Diaz, Corinne Barbuis
  • Novel modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20070054907
    Abstract: Novel compounds that are modulators of PPAR-type receptors having the structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and in the field of cardiovascular diseases, immune diseases and/or diseases linked to the metabolism of lipids), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: June 12, 2006
    Publication date: March 8, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Philippe Diaz, Catherine Raffin
  • Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof
    Publication number: 20060058351
    Abstract: Novel compounds that are ligands of the LXR receptors have the following structural formula (I): and are formulated into pharmaceutical compositions useful in human or veterinary medicine, or alternatively into cosmetic compositions.
    Type: Application
    Filed: August 29, 2005
    Publication date: March 16, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Jean-Michel Bernardon, Etienne Thoreau
  • Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060052627
    Abstract: Novel compounds which modulate PPAR-type receptors have the following general formula (I): and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 9, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Etienne Thoreau, Isabelle Carlavan, Pascale Mauvais, Johannes Voegel
  • Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060035969
    Abstract: Novel compounds which modulate PPAR-type receptors have the following general formula (I): and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
    Type: Application
    Filed: August 12, 2005
    Publication date: February 16, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Etienne Thoreau, Isabelle Carlavan, Pascale Mauvais, Johannes Voegel
  • Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
    Patent number: 6992094
    Abstract: The invention concerns novel diarylselenide compounds corresponding to the general formula (I) and the use thereof in pharmaceutical compositions in human or veterinary medicine (in the treatment of dermatological, rheumatic, cardiovascular and ophthalmologic pathologies in particular), or in cosmetic compositions.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: January 31, 2006
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Jean-Michael Bernardon, Philippe Diaz
  • Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
    Publication number: 20060014803
    Abstract: The invention concerns novel diarylselenide compounds corresponding to formula (I): and the use thereof in pharmaceutical compositions in human or veterinary medicine (in the treatment of dermatological, rheumatic, cardiovascular and ophthalmologic pathologies in particular), or in cosmetic compositions.
    Type: Application
    Filed: September 16, 2005
    Publication date: January 19, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Jean-Michel Bernardon, Philippe Diaz
  • Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
    Publication number: 20050234131
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (1): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Application
    Filed: April 28, 2005
    Publication date: October 20, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them
    Patent number: 6921777
    Abstract: The invention relates to novel heteroethynylenic compounds having the general formula (I): as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and ophthalmological complaints in particular), or alternatively in cosmetic compositions.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: July 26, 2005
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Philippe Diaz, Jean-Michel Bernardon
  • Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
    Patent number: 6818666
    Abstract: Bi-aromatic compounds linked via a heteroethynylene radical are provided along with pharmaceutical and cosmetic compositions containing these compounds and methods for their use.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: November 16, 2004
    Assignee: Galderma Research & Development
    Inventors: Jean-Michel Bernardon, Philippe Diaz
  • Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
    Publication number: 20040162339
    Abstract: The invention relates to novel heterocyclic biaryl compounds which have the general formula (I): 1
    Type: Application
    Filed: February 20, 2004
    Publication date: August 19, 2004
    Inventors: Philippe Diaz, Bruno Charpentier
  • Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
    Publication number: 20030100583
    Abstract: Bi-aromatic compounds linked via a heteroethynylene radical are provided along with pharmaceutical and cosmetic compositions containing these compounds and methods for their use.
    Type: Application
    Filed: August 9, 2002
    Publication date: May 29, 2003
    Applicant: Galderma Research & Development
    Inventors: Jean-Michel Bernardon, Philippe Diaz